BCRX logo

BioCryst Pharmaceuticals, Inc. (BCRX) Operating Expenses

Annual Operating Expenses:

$440.77M+$10.31M(+2.40%)
December 31, 2024

Summary

  • As of today, BCRX annual total operating expenses is $440.77 million, with the most recent change of +$10.31 million (+2.40%) on December 31, 2024.
  • During the last 3 years, BCRX annual operating expenses has risen by +$113.14 million (+34.53%).
  • BCRX annual operating expenses is now at all-time high.

Performance

BCRX Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXincome statement metrics

Quarterly Operating Expenses:

$127.28M-$3.16M(-2.42%)
September 30, 2025

Summary

  • As of today, BCRX quarterly total operating expenses is $127.28 million, with the most recent change of -$3.16 million (-2.42%) on September 30, 2025.
  • Over the past year, BCRX quarterly operating expenses has increased by +$21.43 million (+20.24%).
  • BCRX quarterly operating expenses is now -5.02% below its all-time high of $134.01 million, reached on December 31, 2023.

Performance

BCRX Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXincome statement metrics

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

BCRX Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+2.4%+20.2%
3Y3 Years+34.5%+42.6%
5Y5 Years+205.7%+168.3%

BCRX Operating Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+34.5%-5.0%+42.6%
5Y5-Yearat high+205.7%-5.0%+168.3%
All-TimeAll-Timeat high>+9999.0%-5.0%+1398.3%

BCRX Operating Expenses History

DateAnnualQuarterly
Sep 2025
-
$127.28M(-2.4%)
Jun 2025
-
$130.44M(+9.2%)
Mar 2025
-
$119.41M(-7.9%)
Dec 2024
$440.77M(+2.4%)
$129.60M(+22.4%)
Sep 2024
-
$105.85M(+7.4%)
Jun 2024
-
$98.52M(-6.7%)
Mar 2024
-
$105.55M(-21.2%)
Dec 2023
$430.46M(+4.3%)
$134.01M(+38.0%)
Sep 2023
-
$97.11M(-4.6%)
Jun 2023
-
$101.84M(+6.2%)
Mar 2023
-
$95.85M(-22.1%)
Dec 2022
$412.67M(+26.0%)
$122.96M(+37.7%)
Sep 2022
-
$89.27M(-10.4%)
Jun 2022
-
$99.67M(+0.3%)
Mar 2022
-
$99.33M(+0.6%)
Dec 2021
$327.63M(+71.6%)
$98.75M(+16.5%)
Sep 2021
-
$84.73M(+7.3%)
Jun 2021
-
$79.00M(+22.7%)
Mar 2021
-
$64.37M(+25.9%)
Dec 2020
$190.89M(+32.4%)
$51.13M(+7.8%)
Sep 2020
-
$47.44M(+23.2%)
Jun 2020
-
$38.51M(-15.4%)
Mar 2020
-
$45.51M(+22.1%)
Dec 2019
$144.19M(+26.0%)
$37.26M(+1.6%)
Sep 2019
-
$36.67M(+1.4%)
Jun 2019
-
$36.16M(+7.2%)
Mar 2019
-
$33.73M(+21.4%)
Dec 2018
$114.40M(+41.4%)
$27.79M(-6.5%)
Sep 2018
-
$29.73M(-2.5%)
Jun 2018
-
$30.50M(+17.5%)
Mar 2018
-
$25.96M(+20.6%)
Dec 2017
$80.89M(+11.9%)
$21.53M(+3.3%)
Sep 2017
-
$20.85M(+13.2%)
Jun 2017
-
$18.42M(-7.1%)
Mar 2017
-
$19.83M(+34.7%)
Dec 2016
$72.26M(-15.8%)
$14.72M(-12.2%)
Sep 2016
-
$16.77M(-0.2%)
Jun 2016
-
$16.80M(-29.4%)
Mar 2016
-
$23.79M(+4.4%)
Dec 2015
$85.81M(+44.8%)
-
Sep 2015
-
$22.80M(+13.7%)
Jun 2015
-
$20.06M(-5.3%)
Mar 2015
-
$21.18M(+3.0%)
Dec 2014
$59.26M(+23.6%)
$20.56M(+38.8%)
Sep 2014
-
$14.81M(+13.6%)
Jun 2014
-
$13.04M(+21.0%)
Mar 2014
-
$10.77M(-36.0%)
Dec 2013
$47.95M(-17.7%)
$16.83M(+81.9%)
Sep 2013
-
$9.25M(-28.1%)
Jun 2013
-
$12.87M(+48.0%)
Mar 2013
-
$8.70M(-32.3%)
Dec 2012
$58.29M(-15.8%)
$12.85M(-5.0%)
Sep 2012
-
$13.53M(+32.9%)
Jun 2012
-
$10.18M(+103.5%)
Mar 2012
-
$5.00M(+374.0%)
Dec 2011
$69.23M(-27.6%)
$1.05M(-65.9%)
Sep 2011
-
$3.10M(-18.1%)
Jun 2011
-
$3.78M(+0.2%)
Mar 2011
-
$3.78M(-85.4%)
Dec 2010
$95.62M(+14.1%)
$25.83M(+13.9%)
Sep 2010
-
$22.68M(+29.3%)
Jun 2010
-
$17.55M(-38.0%)
Mar 2010
-
$28.32M(-18.8%)
DateAnnualQuarterly
Dec 2009
$83.78M(+0.1%)
$34.87M(+226.0%)
Sep 2009
-
$10.70M(+22.4%)
Jun 2009
-
$8.74M(-34.5%)
Mar 2009
-
$13.34M(+236.0%)
Dec 2008
$83.73M(-19.1%)
-$9.80M(-202.4%)
Sep 2008
-
$9.57M(-28.5%)
Jun 2008
-
$13.38M(-45.2%)
Mar 2008
-
$24.41M(+612.1%)
Dec 2007
$103.52M(+94.6%)
$3.43M(-71.1%)
Sep 2007
-
$11.86M(+56.4%)
Jun 2007
-
$7.58M(-19.4%)
Mar 2007
-
$9.41M(-12.4%)
Dec 2006
$53.19M(+94.6%)
$10.74M(-34.8%)
Sep 2006
-
$16.46M(+49.4%)
Jun 2006
-
$11.02M(+18.0%)
Mar 2006
-
$9.33M(+24.6%)
Dec 2005
$27.33M(+23.7%)
$7.49M(-5.5%)
Sep 2005
-
$7.93M(+33.6%)
Jun 2005
-
$5.93M(+5.0%)
Mar 2005
-
$5.65M(+5.1%)
Dec 2004
$22.09M(+54.1%)
$5.37M(-1.4%)
Sep 2004
-
$5.45M(+7.8%)
Jun 2004
-
$5.06M(-6.3%)
Mar 2004
-
$5.40M(+16.5%)
Dec 2003
$14.33M(-23.4%)
$4.64M(+37.3%)
Sep 2003
-
$3.38M(+4.7%)
Jun 2003
-
$3.22M(+15.5%)
Mar 2003
-
$2.79M(+15.5%)
Dec 2002
$18.70M(+15.9%)
$2.42M(-31.2%)
Sep 2002
-
$3.52M(-28.3%)
Jun 2002
-
$4.91M(-16.4%)
Mar 2002
-
$5.87M(>+9900.0%)
Dec 2001
$16.14M(+22.8%)
$0.00(-100.0%)
Sep 2001
-
$314.00K(+670.9%)
Jun 2001
-
-$55.00K(-101.3%)
Mar 2001
-
$4.22M(+57.0%)
Dec 2000
$13.15M(+18.4%)
-
Sep 2000
-
$2.69M(-13.2%)
Jun 2000
-
$3.10M(-3.5%)
Mar 2000
-
$3.21M(+28.8%)
Dec 1999
$11.10M(-14.0%)
-
Sep 1999
-
$2.49M(+345.8%)
Jun 1999
-
$559.00K(-80.1%)
Mar 1999
-
$2.81M(+3.5%)
Dec 1998
$12.90M(-7.2%)
$2.72M(-21.8%)
Sep 1998
-
$3.48M(+11.6%)
Jun 1998
-
$3.12M(-3.6%)
Mar 1998
-
$3.23M(-7.6%)
Dec 1997
$13.90M(+28.7%)
$3.50M(+12.9%)
Sep 1997
-
$3.10M(-16.2%)
Jun 1997
-
$3.70M(+362.5%)
Mar 1997
-
$800.00K(-70.4%)
Dec 1996
$10.80M(+285.7%)
$2.70M(-3.6%)
Sep 1996
-
$2.80M(-12.5%)
Jun 1996
-
$3.20M(+52.4%)
Mar 1996
-
$2.10M(+146.7%)
Dec 1995
$2.80M(+12.0%)
-$4.50M(-295.7%)
Sep 1995
-
$2.30M(+21.1%)
Jun 1995
-
$1.90M(-42.4%)
Mar 1995
-
$3.30M(+560.0%)
Dec 1994
$2.50M
$500.00K(-16.7%)
Sep 1994
-
$600.00K(-25.0%)
Jun 1994
-
$800.00K(+14.3%)
Mar 1994
-
$700.00K

FAQ

  • What is BioCryst Pharmaceuticals, Inc. annual total operating expenses?
  • What is the all-time high annual operating expenses for BioCryst Pharmaceuticals, Inc.?
  • What is BioCryst Pharmaceuticals, Inc. annual operating expenses year-on-year change?
  • What is BioCryst Pharmaceuticals, Inc. quarterly total operating expenses?
  • What is the all-time high quarterly operating expenses for BioCryst Pharmaceuticals, Inc.?
  • What is BioCryst Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?

What is BioCryst Pharmaceuticals, Inc. annual total operating expenses?

The current annual operating expenses of BCRX is $440.77M

What is the all-time high annual operating expenses for BioCryst Pharmaceuticals, Inc.?

BioCryst Pharmaceuticals, Inc. all-time high annual total operating expenses is $440.77M

What is BioCryst Pharmaceuticals, Inc. annual operating expenses year-on-year change?

Over the past year, BCRX annual total operating expenses has changed by +$10.31M (+2.40%)

What is BioCryst Pharmaceuticals, Inc. quarterly total operating expenses?

The current quarterly operating expenses of BCRX is $127.28M

What is the all-time high quarterly operating expenses for BioCryst Pharmaceuticals, Inc.?

BioCryst Pharmaceuticals, Inc. all-time high quarterly total operating expenses is $134.01M

What is BioCryst Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?

Over the past year, BCRX quarterly total operating expenses has changed by +$21.43M (+20.24%)
On this page